XML 33 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Sep. 30, 2015 - USD ($)
$ in Thousands
Total
Initial Public Offering
Private Placement
Common Class A
Common Stock Class Undefined
Common Stock Class Undefined
Initial Public Offering
Common Stock Class Undefined
Private Placement
Brink Biologics Inc
Spinout
Additional Paid-in Capital
Additional Paid-in Capital
Initial Public Offering
Additional Paid-in Capital
Private Placement
Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Brink Biologics Inc
Spinout
Beginning Balance at Dec. 31, 2014 $ 58,423     $ 3         $ 71,161       $ (12,741)  
Beginning Balance, Shares at Dec. 31, 2014       61,094,367 0                  
Exercise of stock options 843     $ 1         842          
Exercise of stock options, Shares       949,396 83,588                  
Stock-based compensation expense 140,667               140,667          
Vesting of restricted stock units         485,150                  
Employee payroll taxes withheld related to vesting of restricted stock units (2,415)               (2,415)          
Employee payroll taxes withheld related to vesting of restricted stock units, Shares         (96,612)                  
Adjustment for 1.8515:1 stock split       $ 3         (3)          
Warrants issued in conjunction with Inex Bio acquisition 5,170               5,170          
Exercise of warrants 7,340               7,340          
Exercise of warrants, Shares       4,106,492 565,700                  
Repurchase of common stock (4,798)               (4,798)          
Repurchase of common stock, Shares       (249,952)                    
Reclassification of warrant liability due to exercise 1,544               1,544          
Conversion of Class A common stock to common stock       $ (7) $ 7                  
Conversion of Class A common stock to common stock, Shares       (65,900,303) 65,900,303                  
Issuance of common stock 77,975 $ 221,214 $ 17,000     $ 1     77,975 $ 221,213 $ 17,000      
Issuance of common stock, Shares         4,063,333 9,531,200 680,000              
Spinout of Brink Biologics, Inc.               $ 73           $ 73
Other comprehensive loss (50)                     $ (50)    
Net loss (160,055)                       (160,055)  
Beginning Balance at Sep. 30, 2015 $ 362,931       $ 8       $ 535,696     $ (50) $ (172,723)  
Beginning Balance, Shares at Sep. 30, 2015       0 81,212,662